Recent publications (2023–2024)
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership. Subhani, M., Dhanda, A., Olaru, A., Dunford, L., Ahmad, N., Wragg, A., Frost, K., Greenwood, J., King, M., Jones, K. A., Rosenberg, W., Sinclair, J., Rennick-Egglestone, S., Morling, J. R., Patel, K. & Ryder, S. D. The Lancet Gastroenterology and Hepatology 2024 May 9;5:400-402
Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic review. Archer, A. J., Phillips, J., Subhani, M., Ward, Z., Gordon, F. H., Hickman, M., Dhanda, A.D. & Abeysekera, K. W. M., Liver International 8 Mar 2024;44(6):1298-1308
Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results. Dhanda, A., Andrade, J., Allende, H., Allgar, V., Bailey, M., Callaghan, L., Cocking, L., Goodwin, E., Hawton, A., Hayward, C., Hudson, B., Ingram, W., Jeffery, A., King, A., Lavers, V., Lomax, J., McCune, C. A., Musicha, C., Parker, R. & Rollinson, C. & 2 others, , BMJ Open Gastroenterology. 29 Jan 2024;11(1): e001267.
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022. Li, W., Sheridan, D., McPherson, S., Alazawi, W., Abeysekera, K., Marjot, T., Brennan, P., Mahgoub, S., Cacciottolo, T., Hydes, T., Hardy, T., McGinty, G., Tavabie, O., Cathcart, J., Premathilaka, C., Mukhopadhya, A., Bhat, A., Begum, S., Abushaban, B. & Bhuva, M. et al. JHEP Reports. Dec 2023;5:12
Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis. Mayo, M. J., Vierling, J. M., Bowlus, C. L., Levy, C., Hirschfield, G. M., Neff, G. W., Galambos, M. R., Gordon, S. C., Borg, B. B., Harrison, S. A., Thuluvath, P. J., Goel, A., Shiffman, M. L., Swain, M. G., Jones, D. E. J., Trivedi, P., Kremer, A. E., Aspinall, R. J., Sheridan, D. A. & Dörffel, Y. & 3 others, Alimentary Pharmacology & Therapeutics. 30 Oct 2023: 0, 0
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Razavi-Shearer, D., Gamkrelidze, I., Pan, C., Jia, J., Berg, T., Gray, R., Lim, Y. S., Chen, C. J., Ocama, P., Desalegn, H., Abbas, Z., Abdallah, A., Aghemo, A., Ahmadbekova, S., Ahn, S. H., Aho, I., Akarca, U., Al, M. N., Alalwan, A. & Alavian, S.. Cramp ME et al., Lancet Gastro & Hep. Oct 2023:8(10):879-907
Health promotion and public health. Avades T, Dhanda A. Evidence-Based Nursing Published Online First: 27 July 2023. doi: 10.1136/ebnurs-2023-103751
Satellite liver transplant centres significantly improve transplant assessment outcomes for patients with chronic liver disease but not hepatocellular carcinoma: a retrospective cohort study. Tavabie OD, Kronsten VT, Przemioslo R, Ramos K, Joshi D, Prachalias A, Menon K, Agarwal K, Heneghan MA, Valliani T, Cash J, Cramp ME, Aluvihare V. Frontline Gastroenterology 2023 July;14(4):334-342.
Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocol. Sadler L, Jones H, Whiting P, Rogers M, Watt K,
Cramp M, Ryder S, Stein K, Welton N, Oppe F, Bell J, Rogers G.
NIHR Open Res 2023, 3:23 (https://doi.org/10.3310/nihropenres.13409.1)